Topical therapy with imiquimod for eyelid lesion [3]

Clinical and Experimental Ophthalmology

Volumn 34, Issue 2, 2006, Pages 179-181

  Tsang, Hughie Hc ^a   Huynh, Nghi T ^b   Hollenbach, Eugene ^a  

^a JOHN HUNTER HOSPITAL   (Australia)

^b ROYAL NEWCASTLE HOSPITAL   (Australia)

Author keywords

Bowen's disease; Eyelid tumours; Imiquimod; Skin neoplasms

Indexed keywords

IMIQUIMOD;

ACTINIC KERATOSIS; ADULT; BASAL CELL CARCINOMA; BOWEN DISEASE; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; DRUG TOLERABILITY; EYE IRRITATION; EYELID DISEASE; EYELID ERYTHEMA; FOLLOW UP; HUMAN; INFORMED CONSENT; LETTER; LOWER EYELID; MALE; RECURRENT DISEASE; RISK BENEFIT ANALYSIS; SQUAMOUS CELL CARCINOMA; TELANGIECTASIA; VISUAL SYSTEM EXAMINATION;

ADMINISTRATION, TOPICAL; ADULT; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; BOWEN'S DISEASE; EYELID NEOPLASMS; HUMANS; MALE; SKIN NEOPLASMS;

EID: 33644808346     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2006.01177.x     Document Type: Letter

References (11)

1. Schön M, Bong A, Drewniok C et al. Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod. J Natl Cancer Inst 2003; 95: 1138-49.
2. Geisse J, Cara I, Lindholm J et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 2004; 50: 722-33.
3. Lebwohl M, Dinehart S, Whiting D et al. Imiquimod 5% cream for the treatment of actinic keratosis: Results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials. J Am Acad Dermatol 2004; 50: 715-21.
4. Powell A, Russell-Jones R, Barlow RJ. Topical imiquimod immunotherapy in the management of lentigo maligna. Clin Exp Dermatol 2004; 29: 15-21.
5. Naylor MF, Crowson N, Kuwahara R et al. Treatment of lentigo maligna with topical imiquimod. Br J Dermatol 2003; 149 (Suppl. 66): 66-9.
6. Mackenzie-Wood A, Kossard S, de Launey J, Wilkinson B, Owens M. Imiquimod 5% cream in the treatment of Bowen's disease. J Am Acad Dermatol 2001; 44: 462-70.
7. Smith K, Germani M, Skelton H. Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy. Dermatol Surg 2001; 27: 561-4.
8. Artlette JP. Treatment of Bowen's disease and erythroplasia of Queyrat. Br J Dermatol 2003; 149 (Suppl. 66): 43-7.
9. Chen K, Shmack S. Treatment of Bowen's disease using a cycle regimen o imiquimod 5% cream. Clin Exp Dermatol 2003; 28 (Suppl. 1): 10-2.
10. Wu J, Siller G, Whitehead K. Treatment of Bowen's disease and basal cell carcinoma of the nose with imiquimod 5% cream. Australas J Dermatol 2003; 44: 23-125.
11. Oster-Schmidt C. Two cases of squamous cell carcinoma treated with topical imiquimod 5%. J Eur Acad Dermatol Venereol 2004; 18: 93-5.